Autres langues Becton, Dickinson and Company

Actions

BDX

US0758871091

Equipement, fournitures et distribution médicale

Temps réel estimé 19:08:13 13/08/2026 Varia. 5j. Varia. 1 janv.
182,58 USD -0,54% Graphique intraday de Becton, Dickinson and Company +3,19% -5,85%

Autres langues

18:00 Becton, Dickinson's Consistent Mid-Single-Digit Organic Growth is 12-18 Months Away, RBC Says
12/08 Becton Dickinson & Co Insider Sold Shares Worth $440,888, According to a Recent SEC Filing
12/08 Becton, Dickinson Completes Enrollment in Trial for Phasix Mesh
12/08 BD Accelerates Advanced Tissue Regeneration Strategy with Landmark PREVENT Trial
12/08 Becton, Dickinson And Company Completes Enrollment In The PREVENT Clinical Trial Evaluating Phasix Mesh For Incisional Hernia Prevention
07/08 Becton, Dickinson's Fiscal Q3 Results Show Progress Amid Major Headwinds, RBC Says
06/08 Becton Dickinson Lifts Full-Year Profit Outlook as Third-Quarter Results Top Views
06/08 Becton, Dickinson and Company Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2026
06/08 Becton, Dickinson and Company Updates Revenue Growth Guidance for the Full Year Fiscal 2026
06/08 Stocks Mostly Up Pre-Bell as Investors Weigh Potential Iran-Oman Hormuz Deal, Await More Earnings
06/08 Becton, Dickinson Fiscal Q3 Adjusted Earnings, Revenue Rise; Lifts 2026 Adjusted EPS Guidance
06/08 Becton Dickinson raises lower end of annual profit forecast on drug delivery devices strength
06/08 (BDX) Becton Dickinson Expects Fiscal 2026 Adjusted EPS Range $12.62 to $12.72,vs. FactSet Est of $12.61
06/08 Becton Dickinson: Fiscal Q3 Earnings Snapshot
06/08 Earnings Flash (BDX) Becton, Dickinson and Company Reports Q3 Revenue $4.98B
06/08 Earnings Flash (BDX) Becton, Dickinson and Company Posts Q3 Adjusted EPS $3.23 per Share
06/08 BD Reports Third Quarter Fiscal 2026 Financial Results
04/08 Waters lifts annual forecasts on strong lab-equipment and diagnostics demand
31/07 Becton Dickinson issues recall on certain lots of needle sets used for emergency IV access
31/07 Becton Dickinson and : BD Issues Nationwide Recall for Specific Lots of BD® Intraosseous Vascular Access System Needle Sets Due to Reports of Difficulty Removing the Obturator
29/07 Becton, Dickinson And Company And EMS Announce Collaboration For Semaglutide Launch In Brazil
29/07 EMS and BD expand access to GLP-1 therapies in Brazil with semaglutide launch
28/07 Becton, Dickinson Keeps Quarterly Dividend of $1.05 per Share, Payable September 30 to Shareholders of Record September 9
28/07 Becton, Dickinson and Company Declares Quarterly Dividend, Payable on September 30, 2026
28/07 BD Board Declares Dividend
Aucun résultat pour cette recherche